Matches in Nanopublications for { ?s ?p "[17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP160188.RABEJCNtmFhHILR7VsM41RdGQrUN58LZ1DBBU48xwV83c130_assertion description "[17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP160188.RABEJCNtmFhHILR7VsM41RdGQrUN58LZ1DBBU48xwV83c130_provenance.
- assertion description "[17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP582706.RAUwjiHXOUTqAxYmpRGv6o9-n-XV99LNcVnB0lKPQgZh8130_assertion description "[17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582706.RAUwjiHXOUTqAxYmpRGv6o9-n-XV99LNcVnB0lKPQgZh8130_provenance.
- NP582707.RATZ0In2_H3PaHnRofqymYqWDfpUTNaKzjee7tUZinXpc130_assertion description "[17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582707.RATZ0In2_H3PaHnRofqymYqWDfpUTNaKzjee7tUZinXpc130_provenance.
- NP582709.RAvqUQ9Ra0gQiZhp-MRTOF1GTuDi7cIMlIoltBg1D9Ac0130_assertion description "[17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582709.RAvqUQ9Ra0gQiZhp-MRTOF1GTuDi7cIMlIoltBg1D9Ac0130_provenance.
- NP582708.RA0RArujjuggzfxF5jyu5ZeL_3xbJfLkRZVd4bNpuQrNI130_assertion description "[17beta-hydroxysteroid dehydrogenase 14 affects estradiol levels in breast cancer cells and is a prognostic marker in estrogen receptor-positive breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP582708.RA0RArujjuggzfxF5jyu5ZeL_3xbJfLkRZVd4bNpuQrNI130_provenance.